Literature DB >> 30562041

Mechanisms and Management of Asthma Exacerbations.

J Michael Ramsahai1,2, Philip M Hansbro1,3, Peter A B Wark1.   

Abstract

Acute asthma remains an important medical emergency, the most frequent cause of acute admissions in children and a major source of morbidity for adults with asthma. In all ages with asthma, the presence of exacerbations is an important defining characteristic of asthma severity. In this review, we assess the epidemiology of acute asthma, the triggers of acute exacerbations, and the mechanisms that underlie these exacerbations. We also assess current treatments that prevent exacerbations, with an emphasis on the role of type 2 airway inflammation in the context of acute exacerbations and the novel treatments that effectively target this. Finally we review current management strategies of the exacerbations themselves.

Entities:  

Keywords:  asthma; asthma exacerbations; management of acute asthma; virus-induced asthma exacerbations

Year:  2019        PMID: 30562041     DOI: 10.1164/rccm.201810-1931CI

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  22 in total

1.  Is guideline-based education prehospitalization associated with improved inhaler technique in high-risk children?

Authors:  Helen Wei; Valerie G Press; Anna Volerman
Journal:  Ann Allergy Asthma Immunol       Date:  2021-12-01       Impact factor: 6.347

Review 2.  Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children.

Authors:  Kayleigh M Kew; Ella Flemyng; Bradley S Quon; Clarus Leung
Journal:  Cochrane Database Syst Rev       Date:  2022-09-26

3.  Economic burden of severe asthma treatment: A real-life study.

Authors:  Jesús López-Tiro; Angelica Contreras-Contreras; M Eunice Rodríguez-Arellano; Paula Costa-Urrutia
Journal:  World Allergy Organ J       Date:  2022-07-04       Impact factor: 5.516

4.  Distinct Chronic Post-Viral Lung Diseases upon Infection with Influenza or Parainfluenza Viruses Differentially Impact Superinfection Outcome.

Authors:  Geyon L Garcia; Alex Valenzuela; Tomaz Manzoni; Andrew E Vaughan; Carolina B López
Journal:  Am J Pathol       Date:  2019-12-19       Impact factor: 4.307

5.  Huanglong Antitussive Granule Relieves Acute Asthma Through Regulating Pulmonary Lipid Homeostasis.

Authors:  Hua Yan; Guiying Qian; Rui Yang; Zichen Luo; Xianzheng Wang; Tong Xie; Xia Zhao; Jinjun Shan
Journal:  Front Pharmacol       Date:  2021-04-23       Impact factor: 5.810

Review 6.  Oral corticosteroids stewardship for asthma in adults and adolescents: A position paper from the Thoracic Society of Australia and New Zealand.

Authors:  John Blakey; Li Ping Chung; Vanessa M McDonald; Laurence Ruane; John Gornall; Chris Barton; Sinthia Bosnic-Anticevich; John Harrington; Mark Hew; Anne E Holland; Trudy Hopkins; Lata Jayaram; Helen Reddel; John W Upham; Peter G Gibson; Philip Bardin
Journal:  Respirology       Date:  2021-09-29       Impact factor: 6.175

7.  Metabolomic Associations of Asthma in the Hispanic Community Health Study/Study of Latinos.

Authors:  Yura Lee; Han Chen; Wei Chen; Qibin Qi; Majid Afshar; Jianwen Cai; Martha L Daviglus; Bharat Thyagarajan; Kari E North; Stephanie J London; Eric Boerwinkle; Juan C Celedón; Robert C Kaplan; Bing Yu
Journal:  Metabolites       Date:  2022-04-16

Review 8.  Treatable traits in acute exacerbations of chronic airway diseases.

Authors:  Vanessa M McDonald; Christian R Osadnik; Peter G Gibson
Journal:  Chron Respir Dis       Date:  2019 Jan-Dec       Impact factor: 2.444

Review 9.  The Interplay between Host Immunity and Respiratory Viral Infection in Asthma Exacerbation.

Authors:  Ferdaus Mohd Altaf Hossain; Jin Young Choi; Erdenebileg Uyangaa; Seong Ok Park; Seong Kug Eo
Journal:  Immune Netw       Date:  2019-09-09       Impact factor: 6.303

Review 10.  Rational oral corticosteroid use in adult severe asthma: A narrative review.

Authors:  Li Ping Chung; John W Upham; Philip G Bardin; Mark Hew
Journal:  Respirology       Date:  2019-11-12       Impact factor: 6.424

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.